home / stock / eols / eols news


EOLS News and Press, Evolus Inc. From 03/01/26

Stock Information

Company Name: Evolus Inc.
Stock Symbol: EOLS
Market: NASDAQ
Website: evolus.com

Menu

EOLS EOLS Quote EOLS Short EOLS News EOLS Articles EOLS Message Board
Get EOLS Alerts

News, Short Squeeze, Breakout and More Instantly...

EOLS - Quant snapshot: Impala Platinum, Turkcell Iletisim lead strong buys as Evolus lag

2026-03-01 23:48:16 ET More on earnings Earnings week ahead: AVGO, CRWD, PLUG, COST, TGT, MRVL, JD, KR, and more Earnings scoreboard: 44 of 51 companies posted revenue growth in latest week Upcoming earnings calendar Read the full article on Seeking...

EOLS - Evolus to Participate in The Leerink Partners Global Healthcare Conference

Evolus, Inc. (NASDAQ: EOLS), a performance beauty company with a focus on building an aesthetic portfolio of consumer brands, today announced members of its management team will participate in a fireside chat and investor meetings at the upcoming Leerink Partners Global Healthcare Conference in...

EOLS - Evolus to Report Fourth Quarter and Full-Year 2025 Financial Results on March 3, 2026

Evolus, Inc. (NASDAQ: EOLS), a performance beauty company with a focus on building an aesthetic portfolio of consumer brands, today announced that it will report its fourth quarter and full-year 2025 financial results on Tuesday, March 3, 2026, after the U.S. financial markets close. Evolus...

EOLS - Evolus sees Q4 net revenue between $88.6M and $90.6M

2026-01-09 08:49:06 ET More on Evolus Evolus: A Difficult 2025 Means I'm Downgrading Stock To 'Hold' For 2026 Evolus GAAP EPS of -$0.24 beats by $0.03, revenue of $69M beats by $1.58M Seeking Alpha’s Quant Rating on Evolus Read the full article o...

EOLS - Evolus Announces Preliminary Unaudited Fourth Quarter and Full-Year 2025 Net Revenue

Provides 2026 Net Revenue Guidance and Maintains Projection for Full-Year 2026 Profitability 1 Preliminary Unaudited Net Revenue of $88.6 Million to $90.6 Million for the Fourth Quarter 2025, Representing 12% to 15% Growth Over the Prior Year; Company Reaffirms an Important Mileston...

EOLS - Evolus: A Difficult 2025 Means I'm Downgrading Stock To 'Hold' For 2026

2025-12-17 16:42:01 ET Investment Overview I've covered Evolus ( EOLS ), the Newport Beach, California-headquartered medical aesthetics company, in three prior notes for Seeking Alpha, in March 2024 , January this year , and most recently in July this year , previewi...

EOLS - AMG Frontier Small Cap Growth Fund: Q3 Sees Strong Outperformance Across Semiconductor Holdings

2025-12-14 23:30:00 ET The following segment was excerpted from the AMG Frontier Small Cap Growth Fund ( MSSCX ) Q3 2025 Commentary. ... Read the full article on Seeking Alpha For further details see: AMG Frontier Small Cap Growth...

EOLS - InMode's Shares Are Too Cheap To Ignore: The Bottom May Be In

2025-12-11 18:26:13 ET Company Background InMode Ltd. ( INMD ) was founded in 2008 and is based in Israel. It is a global leader in non-/minimally invasive aesthetic medical products, which are based on their proprietary radiofrequency ((RF)) assisted lipolysis and deep subd...

EOLS - Evolus, Inc. (EOLS) Q3 2025 Earnings Call Transcript

2025-11-08 16:16:07 ET Evolus, Inc. (EOLS) Q3 2025 Earnings Call November 5, 2025 4:30 PM EST Company Participants Nareg Sagherian - Head of Global Investor Relations & Corporate Communications David Moatazedi - President, CEO & Director Rui Avelar - Chief ...

EOLS - Evolus GAAP EPS of -$0.24 beats by $0.03, revenue of $69M beats by $1.58M

2025-11-05 16:42:39 ET More on Evolus Seeking Alpha’s Quant Rating on Evolus Historical earnings data for Evolus Financial information for Evolus Read the full article on Seeking Alpha For further details see: Evolus GAAP EPS of -$0.24 beat...

Previous 10 Next 10